Logo image of HNGR

HANGER INC (HNGR) Stock Fundamental Analysis

NYSE:HNGR - New York Stock Exchange, Inc. - US41043F2083 - Common Stock - Currency: USD

18.72  0 (0%)

After market: 18.72 0 (0%)

Fundamental Rating

2

HNGR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. HNGR may be in some trouble as it scores bad on both profitability and health. HNGR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HNGR was profitable.
HNGR Yearly Net Income VS EBIT VS OCF VS FCFHNGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA 3.86%
ROE 29.78%
ROIC 7.59%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HNGR Yearly ROA, ROE, ROICHNGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 100 -100 200 300

1.3 Margins

Industry RankSector Rank
OM 6.01%
PM (TTM) 3.17%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HNGR Yearly Profit, Operating, Gross MarginsHNGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HNGR is still creating some value.
HNGR has more shares outstanding than it did 1 year ago.
The debt/assets ratio for HNGR has been reduced compared to a year ago.
HNGR Yearly Shares OutstandingHNGR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
HNGR Yearly Total Debt VS Total AssetsHNGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that HNGR is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 3.71 is on the high side and indicates that HNGR has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 3.71
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACC1
WACC7.58%
HNGR Yearly LT Debt VS Equity VS FCFHNGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.23 indicates that HNGR should not have too much problems paying its short term obligations.
HNGR has a Quick Ratio of 1.23. This is a bad value and indicates that HNGR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.85
HNGR Yearly Current Assets VS Current LiabilitesHNGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.00% over the past year.
HNGR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.45% yearly.
Looking at the last year, HNGR shows a quite strong growth in Revenue. The Revenue has grown by 11.72% in the last year.
The Revenue has been growing slightly by 1.46% on average over the past years.
EPS 1Y (TTM)32%
EPS 3Y8.37%
EPS 5Y-11.45%
EPS Q2Q%29.63%
Revenue 1Y (TTM)11.72%
Revenue growth 3Y2.23%
Revenue growth 5Y1.46%
Sales Q2Q%11.12%

3.2 Future

Based on estimates for the next years, HNGR will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.17% on average per year.
HNGR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.78% yearly.
EPS Next Y18.65%
EPS Next 2Y11.76%
EPS Next 3Y9.66%
EPS Next 5Y9.17%
Revenue Next Year7.98%
Revenue Next 2Y5.28%
Revenue Next 3Y4.6%
Revenue Next 5Y4.78%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HNGR Yearly Revenue VS EstimatesHNGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
HNGR Yearly EPS VS EstimatesHNGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

HNGR is valuated rather expensively with a Price/Earnings ratio of 18.91.
HNGR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.48.
HNGR is valuated correctly with a Price/Forward Earnings ratio of 15.29.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.52, HNGR is valued rather cheaply.
Industry RankSector Rank
PE 18.91
Fwd PE 15.29
HNGR Price Earnings VS Forward Price EarningsHNGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.51
HNGR Per share dataHNGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

HNGR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.01
PEG (5Y)N/A
EPS Next 2Y11.76%
EPS Next 3Y9.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HNGR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HANGER INC

NYSE:HNGR (9/30/2022, 8:25:44 PM)

After market: 18.72 0 (0%)

18.72

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-08 2022-08-08/amc
Earnings (Next)11-07 2022-11-07/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners0.76%
Ins Owner Change0%
Market Cap732.39M
Analysts80
Price Target23.84 (27.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.91
Fwd PE 15.29
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 5.85
P/tB N/A
EV/EBITDA 11.51
EPS(TTM)0.99
EY5.29%
EPS(NY)1.22
Fwd EY6.54%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS30.05
BVpS3.2
TBVpSN/A
PEG (NY)1.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.86%
ROE 29.78%
ROCE N/A
ROIC 7.59%
ROICexc N/A
ROICexgc 16.72%
OM 6.01%
PM (TTM) 3.17%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 3.71
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.85
Altman-Z 1.67
F-Score6
WACC7.58%
ROIC/WACC1
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y8.37%
EPS 5Y-11.45%
EPS Q2Q%29.63%
EPS Next Y18.65%
EPS Next 2Y11.76%
EPS Next 3Y9.66%
EPS Next 5Y9.17%
Revenue 1Y (TTM)11.72%
Revenue growth 3Y2.23%
Revenue growth 5Y1.46%
Sales Q2Q%11.12%
Revenue Next Year7.98%
Revenue Next 2Y5.28%
Revenue Next 3Y4.6%
Revenue Next 5Y4.78%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A